144 related articles for article (PubMed ID: 20066751)
1. Controversies about the use of serological markers in diagnosis of inflammatory bowel disease.
Xie Q; Gan HT
World J Gastroenterol; 2010 Jan; 16(2):279-80. PubMed ID: 20066751
[TBL] [Abstract][Full Text] [Related]
2. Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease.
Song WB; Lv YH; Zhang ZS; Li YN; Xiao LP; Yu XP; Wang YY; Ji HL; Ma L
World J Gastroenterol; 2009 Aug; 15(31):3916-9. PubMed ID: 19701972
[TBL] [Abstract][Full Text] [Related]
3. What is the role of serological markers in the diagnosis of IBD?
Dubinsky MC
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S185-6. PubMed ID: 18816787
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.
Estruch JJ; Barken D; Bennett N; Krawiec DK; Ogilvie GK; Powers BE; Polansky BJ; Sueda MT
J Vet Intern Med; 2020 May; 34(3):1177-1186. PubMed ID: 32282988
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.
Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S
Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670
[TBL] [Abstract][Full Text] [Related]
6. Utility of serological markers in inflammatory bowel diseases: gadget or magic?
Papp M; Norman GL; Altorjay I; Lakatos PL
World J Gastroenterol; 2007 Apr; 13(14):2028-36. PubMed ID: 17465443
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children.
Gupta SK; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR
Inflamm Bowel Dis; 2004 May; 10(3):240-4. PubMed ID: 15290918
[TBL] [Abstract][Full Text] [Related]
8. Serological markers in inflammatory bowel diseases.
Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
[TBL] [Abstract][Full Text] [Related]
9. Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
Chandradevan R; Hofmekler T; Mondal K; Harun N; Venkateswaran S; Somineni HK; Ballengee CR; Kim MO; Griffiths A; Noe JD; Crandall WV; Snapper S; Rabizadeh S; Rosh JR; Walters TD; Bertha M; Dubinsky MC; Denson LA; Sauer CG; Markowitz JF; LeLeiko NS; Hyams JS; Kugathasan S
Inflamm Bowel Dis; 2018 Sep; 24(10):2285-2290. PubMed ID: 29860529
[TBL] [Abstract][Full Text] [Related]
10. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
Ruan P; Gong ZJ; Zhang QR
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
[TBL] [Abstract][Full Text] [Related]
11. Serological markers in inflammatory bowel disease: a review of their clinical utility.
Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK
Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012
[TBL] [Abstract][Full Text] [Related]
12. Serological antibodies in inflammatory bowel disease: a systematic review.
Prideaux L; De Cruz P; Ng SC; Kamm MA
Inflamm Bowel Dis; 2012 Jul; 18(7):1340-55. PubMed ID: 22069240
[TBL] [Abstract][Full Text] [Related]
13. New serological biomarkers of inflammatory bowel disease.
Li X; Conklin L; Alex P
World J Gastroenterol; 2008 Sep; 14(33):5115-24. PubMed ID: 18777587
[TBL] [Abstract][Full Text] [Related]
14. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
Nardone OM; Shivaji UN; Ferruzza V; Ghosh S; Iacucci M
Inflamm Bowel Dis; 2020 May; 26(6):961-969. PubMed ID: 31587036
[TBL] [Abstract][Full Text] [Related]
15. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
Mendoza JL; Abreu MT
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
[TBL] [Abstract][Full Text] [Related]
16. ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?
Zhou G; Song Y; Yang W; Guo Y; Fang L; Chen Y; Liu Z
Dig Dis; 2016; 34(1-2):90-7. PubMed ID: 26982193
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.
Chen CS; Sullivan S; Anderson T; Tan AC; Alex PJ; Brant SR; Cuffari C; Bayless TM; Talor MV; Burek CL; Wang H; Li R; Datta LW; Wu Y; Winslow RL; Zhu H; Li X
Mol Cell Proteomics; 2009 Aug; 8(8):1765-76. PubMed ID: 19357087
[TBL] [Abstract][Full Text] [Related]
18. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
[TBL] [Abstract][Full Text] [Related]
19. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
Xu X; Liu L; Yao S; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
Elitsur Y; Lawrence Z; Tolaymat N
J Clin Gastroenterol; 2005 Sep; 39(8):670-3. PubMed ID: 16082274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
